BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 8983283)

  • 1. Randomised comparison of ceftazidime and imipenem as initial monotherapy for febrile episodes in neutropenic cancer patients.
    Aparicio J; Oltra A; Llorca C; Montalar J; Herranz C; Gómez-Codina J; Pastor M; Munárriz B
    Eur J Cancer; 1996 Sep; 32A(10):1739-43. PubMed ID: 8983283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Imipenem/cilastatin versus ceftazidime-amikacin in the treatment of febrile neutropenic patients].
    Pérez C; Sirham M; Labarca J; Grebe G; Lira P; Oliva J; Duhalde M; Ocqueteau M; Acuña G
    Rev Med Chil; 1995 Mar; 123(3):312-20. PubMed ID: 8525170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized comparison of cefepime versus ceftazidime monotherapy for fever and neutropenia in children with solid tumors.
    Kebudi R; Görgün O; Ayan I; Gürler N; Akici F; Töreci K
    Med Pediatr Oncol; 2001 Apr; 36(4):434-41. PubMed ID: 11260566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of imipenem to ceftazidime with or without amikacin as empiric therapy in febrile neutropenic patients.
    Rolston KV; Berkey P; Bodey GP; Anaissie EJ; Khardori NM; Joshi JH; Keating MJ; Holmes FA; Cabanillas FF; Elting L
    Arch Intern Med; 1992 Feb; 152(2):283-91. PubMed ID: 1739355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cefepime monotherapy as an empirical initial treatment of patients with febrile neutropenia.
    Montalar J; Segura A; Bosch C; Galan A; Juan O; Molins C; Giner V; Aparicio J
    Med Oncol; 2002; 19(3):161-6. PubMed ID: 12482126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meropenem monotherapy versus combination therapy with ceftazidime and amikacin for empirical treatment of febrile neutropenic patients.
    Behre G; Link H; Maschmeyer G; Meyer P; Paaz U; Wilhelm M; Hiddemann W
    Ann Hematol; 1998 Feb; 76(2):73-80. PubMed ID: 9540761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cefepime versus ceftazidime as empiric monotherapy for fever and neutropenia in children with cancer.
    Chuang YY; Hung IJ; Yang CP; Jaing TH; Lin TY; Huang YC
    Pediatr Infect Dis J; 2002 Mar; 21(3):203-9. PubMed ID: 12005083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monotherapy for fever and neutropenia in cancer patients: a randomized comparison of ceftazidime versus imipenem.
    Freifeld AG; Walsh T; Marshall D; Gress J; Steinberg SM; Hathorn J; Rubin M; Jarosinski P; Gill V; Young RC
    J Clin Oncol; 1995 Jan; 13(1):165-76. PubMed ID: 7799016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ceftazidime versus imipenem-cilastatin as initial monotherapy for febrile neutropenic patients.
    Liang R; Yung R; Chiu E; Chau PY; Chan TK; Lam WK; Todd D
    Antimicrob Agents Chemother; 1990 Jul; 34(7):1336-41. PubMed ID: 2201252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imipenem compared with ceftazidime plus vancomycin as initial therapy for fever in neutropenic children with cancer.
    Riikonen P
    Pediatr Infect Dis J; 1991 Dec; 10(12):918-23. PubMed ID: 1766707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meropenem versus ceftazidime in the treatment of cancer patients with febrile neutropenia: a randomized, double-blind trial.
    Feld R; DePauw B; Berman S; Keating A; Ho W
    J Clin Oncol; 2000 Nov; 18(21):3690-8. PubMed ID: 11054442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meropenem versus ceftazidime as empirical monotherapy in febrile neutropenia of paediatric patients with cancer.
    Fleischhack G; Hartmann C; Simon A; Wulff B; Havers W; Marklein G; Hasan C; Bode U
    J Antimicrob Chemother; 2001 Jun; 47(6):841-53. PubMed ID: 11389117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monotherapy with meropenem versus combination therapy with ceftazidime plus amikacin as empirical therapy for neutropenic fever in children with malignancy.
    Hung KC; Chiu HH; Tseng YC; Wang JH; Lin HC; Tsai FJ; Peng CT
    J Microbiol Immunol Infect; 2003 Dec; 36(4):254-9. PubMed ID: 14723254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meropenem versus ceftazidime as empirical monotherapy for febrile neutropenic cancer patients.
    Vandercam B; Gérain J; Humblet Y; Ferrant A; Wauters G; Moreau M; Longueville J; Symann M; Straetmans N
    Ann Hematol; 2000 Mar; 79(3):152-7. PubMed ID: 10803938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinafloxacin monotherapy (CI-960) versus ceftazidime plus amikacin for empirical treatment of febrile neutropenic cancer patients.
    Glauser MP; Brennscheidt U; Cornely O; Grigg A; Figuera A; Keyserling C; Trostmann U; Welling L; Tack K
    Clin Microbiol Infect; 2002 Jan; 8(1):14-25. PubMed ID: 11906496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meropenem versus ceftazidime plus amikacin in the treatment of febrile episodes in neutropenic patients: a randomized study.
    de la Cámara R; Figuera A; Sureda A; Hermida G; Verge G; Olalla I; Fernández Rañada JM; Domingo Albos A
    Haematologica; 1997; 82(6):668-75. PubMed ID: 9580087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Equivalent efficacies of meropenem and ceftazidime as empirical monotherapy of febrile neutropenic patients. The Meropenem Study Group of Leuven, London and Nijmegen.
    J Antimicrob Chemother; 1995 Jul; 36(1):185-200. PubMed ID: 8537265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized trial comparing netilmicin plus imipenem-cilastatin versus netilmicin plus ceftazidime as empiric therapy for febrile neutropenic bone marrow transplant recipients.
    Laszlo D; Bacci S; Bosi A; Fanci R; Guidi S; Saccardi R; Vannucchi AM; Rossi Ferrini P
    J Chemother; 1997 Apr; 9(2):95-101. PubMed ID: 9176746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of cefepime + netilmicin or ceftazidime + amikacin or meropenem monotherapy in febrile neutropenic children with malignancy in Turkey.
    Agaoglu L; Devecioglu O; Anak S; Karakas Z; Yalman N; Biner B; Eryilmaz E; Goksan B; Unuvar A; Agirbasli H; Can M; Bilgen H; Gedikoglu G
    J Chemother; 2001 Jun; 13(3):281-7. PubMed ID: 11450887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative study of cefepime versus ceftazidime in the empiric treatment of pediatric cancer patients with fever and neutropenia.
    Mustafa MM; Carlson L; Tkaczewski I; McCracken GH; Buchanan GR
    Pediatr Infect Dis J; 2001 Mar; 20(3):362-9. PubMed ID: 11303851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.